Andrew Gross

Andrew Gross, MD is a Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine. He serves as Rheumatology Clinic Chief, overseeing clinical care, education, and research activities. He is co-director of the UCSF Scleroderma Center and collaborates with the Interstitial Lung Disease Program to provide multidisciplinary care for complex autoimmune conditions. His research focuses on translational studies investigating rheumatic disease mechanisms and improving clinical care strategies. Dr. Gross earned his MD from Tufts University School of Medicine (1996), a BS in Biology from Bates College (1991), and completed a Diversity, Equity, and Inclusion Champion Training at UCSF (2018). He holds an ORCID identifier (0000-0003-0439-1785).

Education:

• M.D., Tufts University School of Medicine, 1996
• B.S., Biology, Bates College, 1991
• Diversity, Equity, and Inclusion Champion Training, UCSF, 2018

Research Interests: Autoimmune diseases, scleroderma, interstitial lung disease, translational medicine, and rheumatoid arthritis biomarkers.
Awards/Grants: Principal Investigator for NIH K08AI052249 (2003-2008) studying EBV in systemic lupus erythematosus.
Advisees/Grants: Collaborates with fellows and junior faculty in translational research programs.
Labs/Teams: Leads rheumatology clinical and research programs at UCSF, including the Scleroderma Center and Interstitial Lung Disease Program.